 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Atara Biotherapeutics (ATRA Research Report) and Embecta Corporation...

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)

PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ( embecta ) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its...

embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes

Algert Global LLC raised its holdings in shares of Embecta Corp. (NASDAQ:EMBC  Free Report) by 102.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and...

Algert Global LLC Increases Position in Embecta Corp. (NASDAQ:EMBC)

On 2/27/24, Amcor plc (AMCR), Hyatt Hotels Corp (H), and Embecta Corp (EMBC) will all trade ex-dividend for their respective upcoming dividends. Amcor plc will pay its quarterly dividend of...

Ex-Dividend Reminder: Amcor, Hyatt Hotels Corp and Embecta Corp

Embecta Corp. (NASDAQ:EMBC  Get Free Report) Director David F. Melcher bought 2,000 shares of Embecta stock in a transaction that occurred on Monday, February 12th. The shares were acquired at...

Embecta Corp. (NASDAQ:EMBC) Director Acquires $32,500.00 in Stock

Embecta Corp. (NASDAQ:EMBC  Get Free Report) Director David F. Melcher acquired 2,000 shares of Embecta stock in a transaction dated Monday, February 12th. The shares were purchased at an...

Embecta Corp. (NASDAQ:EMBC) Director David F. Melcher Buys 2,000 Shares of Stock

PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ( embecta or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month...

Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ( embecta ) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and...

embecta Announces Quarterly Cash Dividend

Embecta Corp. (NASDAQ:EMBC  Get Free Report) shares saw unusually-high trading volume on Friday following a better than expected earnings announcement. Approximately 568,432 shares were traded...

Embecta (NASDAQ:EMBC) Sees Strong Trading Volume After Better-Than-Expected Earnings

In trading on Friday, shares of Embecta Corp (EMBC) were yielding above the 4% mark based on its quarterly dividend (annualized to 0.6), with the stock changing hands as low as 14.66 on the...

Embecta (EMBC) Passes Through 4% Yield Mark

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Volume (M)	576,179.00
52-Wk High	$32.00
52-Wk Low	$9.93

EMBC Embecta Corp

About

Feed

News

Sentiment

Earnings

Fundamentals